1. Facile synthesis of MoS 2 @red phosphorus heterojunction for synergistically photodynamic and photothermal therapy of renal cell carcinoma.
- Author
-
Li T, Guan C, Xu L, Li C, Song Z, Zhang N, Yang C, Shen X, Li D, Wei G, and Xu Y
- Subjects
- Humans, Animals, Apoptosis drug effects, Mice, Cell Survival drug effects, Reactive Oxygen Species metabolism, Drug Screening Assays, Antitumor, Photosensitizing Agents pharmacology, Photosensitizing Agents chemistry, Photosensitizing Agents chemical synthesis, Antineoplastic Agents pharmacology, Antineoplastic Agents chemistry, Antineoplastic Agents chemical synthesis, Particle Size, Cell Line, Tumor, Cell Proliferation drug effects, Infrared Rays, Surface Properties, Molybdenum chemistry, Molybdenum pharmacology, Photothermal Therapy, Disulfides chemistry, Disulfides pharmacology, Disulfides chemical synthesis, Photochemotherapy, Phosphorus chemistry, Phosphorus pharmacology, Kidney Neoplasms pathology, Kidney Neoplasms therapy, Kidney Neoplasms drug therapy, Carcinoma, Renal Cell pathology, Carcinoma, Renal Cell therapy, Carcinoma, Renal Cell drug therapy
- Abstract
The therapy of the clear cell renal cell carcinoma (ccRCC) is crucial for the human healthcare due to its easy metastasis and recurrence, as well as resistance to radiotherapy and chemotherapy. In this work, we propose the synthesis of MoS
2 @red phosphorus (MoS2 @RP) heterojunction to induce synergistic photodynamic and photothermal therapy (PDT/PTT) of ccRCC. The MoS2 @RP heterojunction exhibits enhanced spectra absorption in the NIR range and produce local heat-increasing under the NIR laser irradiation compared with pure MoS2 and RP. The high photocatalytic activity of the MoS2 @RP heterojunction contributes to effective transferring of the photo-excited electrons from the RP to MoS2 , which promotes the production of various types of radical oxygen species (ROS) to kill the ccRCC cells. After the NIR irradiation, the MoS2 @RP can effectively induce the apoptosis in the ccRCC cells through localized hyperthermia and the generation of ROS, while exhibiting low cytotoxicity towards normal kidney cells. In comparison to MoS2 , the MoS2 @RP heterojunction shows an approximate increase of 22 % in the lethality rate of the ccRCC cells and no significant change in toxicity towards normal cells. Furthermore, the PDT/PTT treatment using the MoS2 @RP heterojunction effectively eradicates a substantial number of deep-tissue ccRCC cells in vivo without causing significant damage to major organs. This study presents promising effect of the MoS2 @RP heterojunction-based photo-responsive therapy for effective ccRCC treatment., Competing Interests: Declaration of Competing Interest The authors declare no conflict of interest., (Copyright © 2024. Published by Elsevier B.V.)- Published
- 2024
- Full Text
- View/download PDF